Close

Analyst Ratings for Amylin Pharmaceuticals (AMLN)

AMLN Rating Summary

  |   Expand Research on AMLN
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2.3 / 10   Percentile Rank: 15%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/3/2012 Morgan Stanley N/A Upgrade Equalweight
(Underweight)
N/A
(N/A)
30.71
(30.98)
0.88% Details
7/2/2012 BMO Capital N/A Downgrade Market Perform
(Outperform)
N/A
(N/A)
28.20
(30.98)
9.86% Details
Like AMLN Ratings? Also take a look at

AMLN Ratings News